Andra AP fonden Has $36.03 Million Stock Position in The Clorox Company $CLX

Andra AP fonden raised its stake in The Clorox Company (NYSE:CLX) by 94.5% during the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 300,059 shares of the company’s stock after buying an additional 145,759 shares during the quarter. Andra AP fonden’s holdings in Clorox were worth $36,028,000 at the end of the most recent reporting period.

Other large investors also recently made changes to their positions in the company. American National Bank & Trust lifted its position in Clorox by 69.5% in the 2nd quarter. American National Bank & Trust now owns 217 shares of the company’s stock valued at $26,000 after acquiring an additional 89 shares in the last quarter. NewSquare Capital LLC increased its holdings in Clorox by 567.6% during the 2nd quarter. NewSquare Capital LLC now owns 227 shares of the company’s stock worth $27,000 after purchasing an additional 193 shares in the last quarter. Hantz Financial Services Inc. acquired a new stake in shares of Clorox in the 2nd quarter valued at about $31,000. Ransom Advisory Ltd bought a new stake in shares of Clorox in the first quarter valued at about $35,000. Finally, GW&K Investment Management LLC boosted its position in shares of Clorox by 239.1% during the first quarter. GW&K Investment Management LLC now owns 295 shares of the company’s stock worth $43,000 after buying an additional 208 shares during the period. Institutional investors own 78.53% of the company’s stock.

Clorox Trading Down 1.3%

NYSE CLX opened at $108.97 on Thursday. The Clorox Company has a 12 month low of $107.71 and a 12 month high of $171.37. The company has a current ratio of 0.84, a quick ratio of 0.57 and a debt-to-equity ratio of 5.15. The stock has a 50 day moving average of $119.93 and a 200-day moving average of $125.29. The company has a market cap of $13.27 billion, a PE ratio of 16.71, a PEG ratio of 0.92 and a beta of 0.52.

Clorox (NYSE:CLX) last issued its earnings results on Monday, November 3rd. The company reported $0.85 earnings per share for the quarter, topping analysts’ consensus estimates of $0.78 by $0.07. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The business had revenue of $1.43 billion for the quarter, compared to the consensus estimate of $1.41 billion. During the same period in the previous year, the company earned $1.86 earnings per share. The firm’s revenue for the quarter was down 18.9% on a year-over-year basis. Clorox has set its FY 2026 guidance at 5.950-6.300 EPS. On average, equities research analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Thursday, November 6th. Stockholders of record on Wednesday, October 22nd will be issued a $1.24 dividend. This represents a $4.96 dividend on an annualized basis and a dividend yield of 4.6%. The ex-dividend date of this dividend is Wednesday, October 22nd. Clorox’s dividend payout ratio is presently 77.86%.

Analyst Upgrades and Downgrades

A number of equities research analysts recently issued reports on CLX shares. The Goldman Sachs Group dropped their target price on Clorox from $115.00 to $110.00 and set a “sell” rating on the stock in a research report on Wednesday, October 1st. Wells Fargo & Company decreased their price target on shares of Clorox from $125.00 to $117.00 and set an “equal weight” rating for the company in a research note on Tuesday. UBS Group set a $119.00 price objective on shares of Clorox and gave the company a “neutral” rating in a report on Tuesday. Weiss Ratings restated a “hold (c-)” rating on shares of Clorox in a report on Tuesday, October 14th. Finally, Zacks Research downgraded shares of Clorox from a “hold” rating to a “strong sell” rating in a research report on Tuesday, October 28th. One investment analyst has rated the stock with a Buy rating, eleven have issued a Hold rating and five have given a Sell rating to the company. According to MarketBeat, Clorox presently has an average rating of “Reduce” and a consensus target price of $127.60.

Insider Transactions at Clorox

In related news, COO Eric H. Reynolds sold 15,041 shares of Clorox stock in a transaction dated Thursday, September 4th. The stock was sold at an average price of $123.78, for a total transaction of $1,861,774.98. Following the completion of the transaction, the chief operating officer owned 54,221 shares in the company, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Company insiders own 0.63% of the company’s stock.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.